Skip to main content

Part of Cancer staging guidance sheets

Neuroendocrine tumours of the midgut and hindgut

Current Chapter

Current chapter – Neuroendocrine tumours of the midgut and hindgut


Introduction

This is the data sheet for TNM 8th edition staging of neuroendocrine tumours of the midgut and hindgut - lower jejunum and ileum, appendix and colon & rectum


Lower jejunum and ileum

European neuroendocrine tumour society TNM staging summary

Stage Group

T stage

N stage

M stage

Stage I

T1

N0

M0

Stage IIA

T2

N0

M0

Stage IIB

T3

N0

M0

Stage IIIA

T4

N0

M0

Stage IIIB

Any T

N1

M0

Stage IV

Any T

Any N

M1

TNM clinical classification

T - primary tumour

T value Description

TX

Primary tumour cannot be assessed

T0

No evidence of primary tumour

T1

Tumour invades mucosa or submucosa and size ≤1 cm

T2

Tumour invades muscularis propria or size >1 cm

T3

Tumour invades subserosa

T4

Tumour invades peritoneum/other organs

 

For any T add (m) for multiple tumours

 

a - Tumour limited to ampulla of Vater for ampullary gangliocytic paraganglioma

N - regional lymph nodes

N value Description

NX

Regional lymph nodes cannot be assessed

N0

No regional lymph node metastasis

N1

Regional lymph node metastasis

M - distant metastasis

M value Description

MX

Distant metastasis cannot be assessed

M0

No distant metastases

M1

Distant metastasis


Appendix

European neuroendocrine tumour society TNM staging summary

Stage Group

T stage

N stage

M stage

Stage I

T1

N0

M0

Stage IIA

T2

N0

M0

Stage IIB

T3

N0

M0

Stage IIIA

T4

N0

M0

Stage IIIB

Any T

N1

M0

Stage IV

Any T

Any N

M1

TNM clinical classification

T - primary tumour

T value Description

TX

Primary tumour cannot be assessed

T0

No evidence of primary tumour

T1

Tumour ≤1 cm invading submucosa and muscularis propria

T2

Tumour ≤2 cm invading submucosa, muscularis propria and/or minimally (up to 3 mm) invading subserosa/mesoappendix

T3

Tumour >2 cm and/or extensive (more than 3 mm) invasion of subserosa/mesoappendix

T4

Tumour invades peritoneum/other organs

 

For any T add (m) for multiple tumours

 

a - Tumour limited to ampulla of Vater for ampullary gangliocytic paraganglioma

N - regional lymph nodes

N value Description

NX

Regional lymph nodes cannot be assessed

N0

No regional lymph node metastasis

N1

Regional lymph node metastasis

M - distant metastasis

M value Description

MX

Distant metastasis cannot be assessed

M0

No distant metastases

M1

Distant metastasis

 


Colon and rectum

European neuroendocrine tumour society TNM staging summary

Stage Group

T stage

N stage

M stage

Stage IA

T1a

N0

M0

Stage IB

T1b

N0

M0

Stage IIA

T2

N0

M0

Stage IIB

T3

N0

M0

Stage IIIA

T4

N0

M0

Stage IIIB

Any T

N1

M0

Stage IV

Any T

Any N

M1

TNM classical classification

T - primary tumour

T value Description

TX

Primary tumour cannot be assessed

T0

No evidence of primary tumour

T1

Tumour invades mucosa or submucosa

T1a - size <1 cm

T1b - size 1–2 cm

T2

Tumour invades muscularis propria or size >2 cm

T3

Tumour invades subserosa/pericolic/perirectal fat

T4

Tumour directly invades other organs/structures and/or perforates visceral peritoneum

 

For any T add (m) for multiple tumours

N - regional lymph nodes

N value Description

NX

Regional lymph node status cannot be assessed

N0

No regional lymph node metastasis

N1

Regional lymph node metastasis

M - distant metastasis

M value Description

MX

Distant metastasis cannot be assessed

M0

No distant metastases

M1

Distant metastasis


Download

Click on the box below to download a PDF version of this data sheet:

Last edited: 16 April 2024 1:33 pm

  1. Cancer staging guidance sheets
  2. Lip and oral cavity (ICD10 C00, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C10-14, C30-32)
  4. Pharynx (ICD10 C01, C05.1-2, C09, C10.0, C10.2-3, C11-13)
  5. Major salivary glands (ICD10 C07, C08)
  6. Oesophagus including oesophagastric junction (ICD10 C15 & C16.0)
  7. Stomach (ICD10 C16 except C16.0)
  8. Small intestine (ICD10 C17)
  9. Appendix (ICD10 C18.1)
  10. Colon and rectum (ICD10 C18-C20)
  11. Anal canal and perianal skin data (ICD10 C21, C44.5)
  12. Liver (ICD10 C22.0)
  13. Intrahepatic bile ducts (ICD10 C22.1)
  14. Gallbladder (ICD10 C23, C24.0)
  15. Distal extrahepatic bile duct (ICD10 C24.0)
  16. Perihilar bile ducts (ICD10 C24.0)
  17. Ampulla of vater (ICD10 C24.1)
  18. Pancreas (ICD10 C25)
  19. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  20. Larynx (ICD10 C32.0 C32.1, C32.2, C10.1)
  21. Lung (ICD10 C34)
  22. Thymic tumours (ICD10 C37)
  23. Soft tissues (ICD10 C38.1-2, C47-C49)
  24. Bone (ICD10 C40 & C41)
  25. Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)
  26. Merkel cell carcinoma of skin (ICD10 C44 & C63.2)
  27. Skin carcinoma of the head and neck (ICD10 C44.0, C44.2-4)
  28. Carcinoma of skin of the eyelid (ICD10 C44.1)
  29. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  30. Pleural mesothelioma (ICD10 C45)
  31. Breast tumours (ICD10 C50)
  32. Vulva (ICD10 C51)
  33. Cervix uteri (ICD10 C53)
  34. Uterine sarcomas
  35. Uterus - endometrium (ICD10 C54.1, C55)
  36. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  37. Gestational trophoblastic neoplasms (ICD10 C58)
  38. Penis tumours (ICD10 C60)
  39. Prostate tumours (ICD10 C61)
  40. Testis tumours (ICD10 C62)
  41. Kidney tumours (ICD10 C64)
  42. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  43. Urinary bladder tumours (ICD10 C67)
  44. Urethra tumours (ICD10 C68.0)
  45. Carcinoma of conjuctiva (ICD10 C69.0)
  46. Malignant melanoma of conjuctiva (ICD10 C69.0)
  47. Retinoblastoma (ICD10 C69.2)
  48. Malignant melanoma of uvea (ICD10 C69.3, C69.4)
  49. Carcinoma of lacrimal gland (ICD10 C69.5)
  50. Sarcoma of orbit (ICD10 C69.6)
  51. Thyroid gland (ICD10 C73)
  52. Adrenal cortex (ICD10 C74.0)
  53. Chronic lymphocytic leukaemia
  54. Hepatoblastoma (CTYA)
  55. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  56. Medulloblastoma
  57. Multiple myeloma
  58. Neuroblastoma
  59. Neuroendocrine tumours of the foregut
  60. Neuroendocrine tumours of the midgut and hindgut
  61. Non-hodgkin lymphoma (children)
  62. Rhabdomyosarcoma and other soft tissue sarcomas (CTYA)
  63. Wilms tumour of the kidney